This article is more than 5 years old. Information may no longer be current.
Prostate Cancer Foundation presents Young Investigator Awards
Click Here to Manage Email Alerts
The Prostate Cancer Foundation granted $6 million to 29 early-career scientists through its Young Investigator Awards program.
“We are honored to invest in new cutting-edge ideas for prostate cancer research. This year’s recipients show great potential for unlocking new discoveries and achieving unprecedented strides toward research leading the way to help countless men affected by the disease,” Jonathan Simons, MD, the foundation’s president and CEO, said in a press release.
The Prostate Cancer Foundation has awarded more than $53 million to 255 young investigators since 2007.
Young Investigator Award recipients must be within six years of completing professional scientific training programs and be under the guidance of at least one mentor. They also must demonstrate significant promise for having a long-term and impactful career in prostate cancer research.
This year’s award recipients are Saud Aldubayan, MD, of Harvard University and Dana-Farber Cancer Institute; Mohammad Asim, PhD, of University of Surrey in United Kingdom; Hala Borno, MD, of University of California, San Francisco; Frank Cackowski, MD, PhD, of University of Michigan; Megan Caram, MD, of University of Michigan; Kellie Cotter, PhD, of University of Bern in Switzerland; Anis Hamid, MBBS, of Harvard University and Dana-Farber Cancer Center; Jennifer Jones, MD, PhD, of NCI; Salma Kaochar, PhD, of Baylor College of Medicine; Sheng-Yu Ku, PhD, of Weill Cornell Medicine; Hui Li, PhD, of University of California, San Francisco; Brandon Mahal, MD, of Harvard University and Dana-Farber Cancer Institute; Danil Makarov, MD, of New York University; Megan McNamara, MD, of Duke University; Kent Mouw, MD, PhD, of Harvard University and Dana-Farber Cancer Institute; Vivek Narayan, MD, of University of Pennsylvania and Abramson Cancer Center, as well as a HemOnc Today Next Gen Innovator; David Oh, MD, PhD, of University of California, San Francisco; Eileen Parkes, MD, PhD, of Queen’s University Belfast in Northern Ireland; Raquel Perez-Lopez, MD, PhD, of Vall d’Hebron Institute of Oncology in Spain; Sethuramasundaram Pitchiaya, PhD, of University of Michigan; Nicholas Reder, MD, MPH, of University of Washington; Zachery Reichert, MD, PhD, of University of Michigan; Veronica Rodriguez-Bravo, PhD, of Thomas Jefferson University and Sidney Kimmel Cancer Center; Joshua Russo, MD, PhD, of Harvard University and Beth Israel Deaconess Medical Center; Adam Sharp, MD, PhD, of Institute of Cancer Research in London; Min Yuen Teo, MD, of Memorial Sloan Kettering Cancer Center; Vasanthi Viswanathan, PhD, of Harvard University and Broad Institute of MIT and Harvard; Scott Wilkinson, PhD, of NCI; and David Wise, MD, PhD, of New York University.